Time to Invest in L...
Health Care: Drugs
NuPathe Inc. (PATH: NASDAQ)
$3.17 0.06 | 1.93%
05/24/13 - 03:59 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | ||
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 22.57M | 23.06M | 38.92M | |
| Receivables | 0.00 | 0.00 | 0.00 | |
| Inventories | 0.00 | 0.00 | 0.00 | |
| Other Current Assets | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 23.02M | 23.39M | 39.93M | |
| Property, Plant & Equipment, Gross | 881.00K | 438.00K | 244.65K | |
| Accumulated Depreciation & Depletion | 300.00K | 225.00K | 146.38K | |
| Property, Plant & Equipment, Net | 581.00K | 213.00K | 98.27K | |
| Intangibles | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 7.01M | 7.24M | 3.73M | |
| Total Non-Current Assets | 7.59M | 7.46M | 3.83M | |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 30.61M | 30.85M | 43.75M | |
| Accounts Payable | 800.00K | 1.97M | 1.20M | |
| Short Term Debt | 378.00K | 8.41M | 1.51M | |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | |
| Total Current Liabilities | 3.17M | 12.40M | 5.78M | |
| Long Term Debt | 8.10M | 5.48M | 3.70M | |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Liabilities | 16.32M | 0.00 | 0.00 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 24.42M | 5.48M | 3.70M | |
| Total Liabilities | 27.59M | 17.88M | 9.49M | |
| Preferred Stock Equity | 7.26M | 0.00 | 0.00 | |
| Common Stock Equity | -4.24M | 12.97M | 34.27M | |
| Common Par | 20.00K | 15.00K | 14.55K | |
| Additional Paid In Capital | 136.51M | 115.94M | 114.05M | |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | |
| Retained Earnings | -140.77M | -102.98M | -79.80M | |
| Treasury Stock | 0.00 | 0.00 | 0.00 | |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | |
| Total Capitalization | 11.12M | 18.45M | 37.97M | |
| Total Equity | 3.01M | 12.97M | 34.27M | |
| Total Liabilities & Stock Equity | 30.61M | 30.85M | 43.75M | |
| Total Common Shares Outstanding | 20.02M | 14.75M | 14.55M | |
| Preferred Shares | 8.80K | 0.00 | 0.00 | |
| Treasury Shares | 0.00 | 0.00 | 0.00 | |
| Basic Weighted Shares Outstanding | 15.21M | 14.63M | 6.13M | |
| Diluted Weighted Shares Outstanding | 15.21M | 14.63M | 6.13M | |
| Number of Employees | 14 | 37 | 26 | |
| Number of Part-Time Employees | 0 | 0 | 0 | |
Portfolios with PATH
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorEarnings Short Squeeze Play...
- ContributorUnder-$10 Setting Up To Tra...
- UserSMITTY
- ContributorHot Biotech Trades for Seco...
- Contributor9 Health Care Stocks With 1...
Latest PATH Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.16.13 | 03:04 pm
- 5 Under-$10 Stocks Primed to Trade Higher 12.20.12 | 12:12 pm
- 2013 FDA Drug Approval Decision Calendar 12.19.12 | 09:12 am
- First 90 Days of 2013 Are Live or Die For These Biotech Stocks 11.19.12 | 09:11 am
- 5 Biotech Stocks Under $5 Blasting Off 08.16.12 | 03:08 pm
- NuPathe Management Discusses Q2 2012 Results - Earnings Call Transcript 08.14.12 | 02:08 pm
- 4 Stocks Under $5 Making Big Moves 07.17.12 | 12:07 pm
- 8 Stocks Under $10 Moving Higher 02.08.12 | 02:02 pm
- 11 Stocks to Watch: NuPathe, Universal Display 08.30.11 | 08:08 am
- FDA Rejects NuPathe Migraine Patch 08.30.11 | 06:08 am
Press Releases for PATH
- Safeguard Scientifics Announces Second Quarter 2011 Financial Results - Business Wire 07.27.11 | 06:07 am
Partner Headlines for PATH
- Pre-Market Earnings Report for March 26, 2013 : NEOG, PLCE, PATH - NASDAQ 03.25.13 | 08:03 pm
- Morning Market Losers - Benzinga 09.26.12 | 09:09 am
- 7 Biotech Stocks Being Snapped Up By Insiders - Seeking Alpha 03.16.12 | 05:03 pm
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- NuPathe Announces Allowance of U.S. Patent Application for NP202 - Benzinga 02.29.12 | 04:02 pm
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Mid-Day Update: US Indexes Recover from Red; Consumer Confidence Data Still Weighs - NASDAQ 08.30.11 | 04:08 pm
- Stocks Recover from Consumer Confidence Data-Induced Slump; Commodities Trending Higher - NASDAQ 08.30.11 | 04:08 pm
- Morning Market Losers - Benzinga 08.30.11 | 09:08 am
